Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Mutations in the KCNQ channel family is often associated with diseases related to the nervous and cardio vascular systems. Small molecules that inhibits these channels may have therapeutic applications. UCL2077 is a lipid permeable compound that inhibits KCNQ1 and KCNQ2 channels.
?您的位置：
